Cargando…

The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis

Bacterial vaginosis (BV), a condition in which the vaginal microbiota consists of community of obligate and facultative anaerobes rather than dominated by a single species of Lactobacillus, affects ~30% of women in the US. Women with BV are at 60% increased risk for HIV acquisition and are 3-times m...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoang, Thuy, Toler, Emily, DeLong, Kevin, Mafunda, Nomfuneko A., Bloom, Seth M., Zierden, Hannah C., Moench, Thomas R., Coleman, Jenell S., Hanes, Justin, Kwon, Douglas S., Lai, Samuel K., Cone, Richard A., Ensign, Laura M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999914/
https://www.ncbi.nlm.nih.gov/pubmed/31971984
http://dx.doi.org/10.1371/journal.ppat.1008236
_version_ 1783493983402459136
author Hoang, Thuy
Toler, Emily
DeLong, Kevin
Mafunda, Nomfuneko A.
Bloom, Seth M.
Zierden, Hannah C.
Moench, Thomas R.
Coleman, Jenell S.
Hanes, Justin
Kwon, Douglas S.
Lai, Samuel K.
Cone, Richard A.
Ensign, Laura M.
author_facet Hoang, Thuy
Toler, Emily
DeLong, Kevin
Mafunda, Nomfuneko A.
Bloom, Seth M.
Zierden, Hannah C.
Moench, Thomas R.
Coleman, Jenell S.
Hanes, Justin
Kwon, Douglas S.
Lai, Samuel K.
Cone, Richard A.
Ensign, Laura M.
author_sort Hoang, Thuy
collection PubMed
description Bacterial vaginosis (BV), a condition in which the vaginal microbiota consists of community of obligate and facultative anaerobes rather than dominated by a single species of Lactobacillus, affects ~30% of women in the US. Women with BV are at 60% increased risk for HIV acquisition and are 3-times more likely to transmit HIV to an uninfected partner. As cervicovaginal mucus (CVM) is the first line of defense against mucosal pathogens and the home of the resident vaginal microbiota, we hypothesized the barrier function of CVM to HIV may be diminished in BV. Here, we characterized CVM properties including pH, lactic acid content, and Nugent score to correlate with the microbiota community composition, which was confirmed by 16S rDNA sequencing on a subset of samples. We then quantified the mobility of fluorescently-labeled HIV virions and nanoparticles to characterize the structural and adhesive barrier properties of CVM. Our analyses included women with Nugent scores categorized as intermediate (4–6) and BV (7–10), women that were either symptomatic or asymptomatic, and a small group of women before and after antibiotic treatment for symptomatic BV. Overall, we found that HIV virions had significantly increased mobility in CVM from women with BV compared to CVM from women with Lactobacillus crispatus-dominant microbiota, regardless of whether symptoms were present. We confirmed using nanoparticles and scanning electron microscopy that the impaired barrier function was due to reduced adhesive barrier properties without an obvious degradation of the physical CVM pore structure. We further confirmed a similar increase in HIV mobility in CVM from women with Lactobacillus iners-dominant microbiota, the species most associated with transitions to BV and that persists after antibiotic treatment for BV. Our findings advance the understanding of the protective role of mucus and highlight the interplay between vaginal microbiota and the innate barrier function mucus.
format Online
Article
Text
id pubmed-6999914
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69999142020-02-18 The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis Hoang, Thuy Toler, Emily DeLong, Kevin Mafunda, Nomfuneko A. Bloom, Seth M. Zierden, Hannah C. Moench, Thomas R. Coleman, Jenell S. Hanes, Justin Kwon, Douglas S. Lai, Samuel K. Cone, Richard A. Ensign, Laura M. PLoS Pathog Research Article Bacterial vaginosis (BV), a condition in which the vaginal microbiota consists of community of obligate and facultative anaerobes rather than dominated by a single species of Lactobacillus, affects ~30% of women in the US. Women with BV are at 60% increased risk for HIV acquisition and are 3-times more likely to transmit HIV to an uninfected partner. As cervicovaginal mucus (CVM) is the first line of defense against mucosal pathogens and the home of the resident vaginal microbiota, we hypothesized the barrier function of CVM to HIV may be diminished in BV. Here, we characterized CVM properties including pH, lactic acid content, and Nugent score to correlate with the microbiota community composition, which was confirmed by 16S rDNA sequencing on a subset of samples. We then quantified the mobility of fluorescently-labeled HIV virions and nanoparticles to characterize the structural and adhesive barrier properties of CVM. Our analyses included women with Nugent scores categorized as intermediate (4–6) and BV (7–10), women that were either symptomatic or asymptomatic, and a small group of women before and after antibiotic treatment for symptomatic BV. Overall, we found that HIV virions had significantly increased mobility in CVM from women with BV compared to CVM from women with Lactobacillus crispatus-dominant microbiota, regardless of whether symptoms were present. We confirmed using nanoparticles and scanning electron microscopy that the impaired barrier function was due to reduced adhesive barrier properties without an obvious degradation of the physical CVM pore structure. We further confirmed a similar increase in HIV mobility in CVM from women with Lactobacillus iners-dominant microbiota, the species most associated with transitions to BV and that persists after antibiotic treatment for BV. Our findings advance the understanding of the protective role of mucus and highlight the interplay between vaginal microbiota and the innate barrier function mucus. Public Library of Science 2020-01-23 /pmc/articles/PMC6999914/ /pubmed/31971984 http://dx.doi.org/10.1371/journal.ppat.1008236 Text en © 2020 Hoang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hoang, Thuy
Toler, Emily
DeLong, Kevin
Mafunda, Nomfuneko A.
Bloom, Seth M.
Zierden, Hannah C.
Moench, Thomas R.
Coleman, Jenell S.
Hanes, Justin
Kwon, Douglas S.
Lai, Samuel K.
Cone, Richard A.
Ensign, Laura M.
The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
title The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
title_full The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
title_fullStr The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
title_full_unstemmed The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
title_short The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis
title_sort cervicovaginal mucus barrier to hiv-1 is diminished in bacterial vaginosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999914/
https://www.ncbi.nlm.nih.gov/pubmed/31971984
http://dx.doi.org/10.1371/journal.ppat.1008236
work_keys_str_mv AT hoangthuy thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT toleremily thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT delongkevin thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT mafundanomfunekoa thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT bloomsethm thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT zierdenhannahc thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT moenchthomasr thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT colemanjenells thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT hanesjustin thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT kwondouglass thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT laisamuelk thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT conericharda thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT ensignlauram thecervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT hoangthuy cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT toleremily cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT delongkevin cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT mafundanomfunekoa cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT bloomsethm cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT zierdenhannahc cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT moenchthomasr cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT colemanjenells cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT hanesjustin cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT kwondouglass cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT laisamuelk cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT conericharda cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis
AT ensignlauram cervicovaginalmucusbarriertohiv1isdiminishedinbacterialvaginosis